Other genome-wide association studies of breast cancer predisposition identified variants on chromosome 5p12 some 274–317 kb distal to the fibroblast growth factor 10 (FGF10) that confer a risk, preferentially for estrogen receptor-positive breast tumors. This evidence concerns the gene FGF10 and breast cancer.